Literature DB >> 19573080

Common genetic variants in candidate genes and risk of familial lymphoid malignancies.

Xueying Sharon Liang1, Neil Caporaso, Mary Lou McMaster, David Ng, Ola Landgren, Meredith Yeager, Stephen Chanock, Lynn R Goldin.   

Abstract

Familial aggregation, linkage and case-control studies support the role of germline genes in the aetiology of lymphoid malignancies. To further examine the role of genetic variation underlying susceptibility, we analysed 1536 single nucleotide polymorphisms in 152 genes involved in apoptosis, DNA repair, immune response and oxidative stress pathways among a unique sample of 165 unrelated familial cases including patients with chronic lymphocytic leukaemia (CLL), Waldenström macroglobulinaemia (WM) and Hodgkin lymphoma (HL), and 107 spouse controls. We confirmed previous studies showing a polymorphism in the IL10 promoter (rs1800890/-3575T>A) to be associated with non-Hodgkin lymphoma, as this allele was found to be associated with both CLL and WM. We also confirmed the role of IL6 variation to be associated with HL. Polymorphisms in TNFSF10 were associated with both CLL and WM. Future replication and functional studies are needed to clarify the role of these genetic variants. Finally, our data further support the close association of WM and CLL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19573080      PMCID: PMC2890251          DOI: 10.1111/j.1365-2141.2009.07790.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  41 in total

1.  Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis.

Authors:  C Vener; A Guffanti; M Pomati; M Colombi; A Alietti; M L La Targia; F Bamonti-Catena; L Baldini
Journal:  Leuk Lymphoma       Date:  2000-04

2.  Controlling the false discovery rate in behavior genetics research.

Authors:  Y Benjamini; D Drai; G Elmer; N Kafkafi; I Golani
Journal:  Behav Brain Res       Date:  2001-11-01       Impact factor: 3.332

3.  Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry.

Authors:  N Ishibe; M T Sgambati; L Fontaine; L R Goldin; N Jain; N Weissman; G E Marti; N E Caporaso
Journal:  Leuk Lymphoma       Date:  2001-06

4.  The future of association studies of common cancers.

Authors:  Richard S Houlston; Julian Peto
Journal:  Hum Genet       Date:  2003-02-06       Impact factor: 4.132

5.  Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Magnus Björkholm; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

6.  A genome scan of 18 families with chronic lymphocytic leukaemia.

Authors:  Lynn R Goldin; Naoko Ishibe; Maria Sgambati; Gerald E Marti; Laura Fontaine; Maxwell P Lee; Jenny M Kelley; Titia Scherpbier; Kenneth H Buetow; Neil E Caporaso
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

7.  Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2008-08-13       Impact factor: 22.113

Review 8.  Autoimmunity and lymphomagenesis.

Authors:  Lynn R Goldin; Ola Landgren
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

Review 9.  Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.

Authors:  Lynn R Goldin; Neil E Caporaso
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

Review 10.  Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.

Authors:  Mary L McMaster; Neil Caporaso
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

View more
  16 in total

1.  Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.

Authors:  Zhi-Ming Dai; Ai-Li He; Wang-Gang Zhang; Jie Liu; Xing-Mei Cao; Yin-Xia Chen; Xiao-Rong Ma; Wan-Hong Zhao; Zhi-Jun Dai
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.

Authors:  Yan Zhang; Zu-Guang Xia; Jin-Hong Zhu; Min-Bin Chen; Tong-Min Wang; Wen-Xiang Shen; Jing He
Journal:  Mol Genet Genomics       Date:  2015-05-15       Impact factor: 3.291

3.  IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach.

Authors:  Polina Stepensky; Michael Weintraub; Asaf Yanir; Shoshana Revel-Vilk; Frank Krux; Kirsten Huck; Rene M Linka; Avraham Shaag; Orly Elpeleg; Arndt Borkhardt; Igor B Resnick
Journal:  Haematologica       Date:  2010-11-25       Impact factor: 9.941

4.  IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls.

Authors:  Bin Xu; Xiao-Bing Niu; Zi-Dun Wang; Wei Cheng; Na Tong; Yuan-Yuan Mi; Zhi-Chao Min; Jun Tao; Peng-Chao Li; Wei Zhang; Hong-Fei Wu; Zheng-Dong Zhang; Zeng-Jun Wang; Li-Xin Hua; Ning-Han Feng; Xin-Ru Wang
Journal:  Mol Biol Rep       Date:  2010-11-23       Impact factor: 2.316

5.  Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Claire M Vajdic; Ola Landgren; Mary L McMaster; Susan L Slager; Angela Brooks-Wilson; Alex Smith; Anthony Staines; Ahmet Dogan; Stephen M Ansell; Joshua N Sampson; Lindsay M Morton; Martha S Linet
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

6.  TNF superfamily gene polymorphism as prognostic factor in early breast cancer.

Authors:  Jin Hyang Jung; Yee Soo Chae; Joon Ho Moon; Byung Woog Kang; Jong Gwang Kim; Sang Kyun Sohn; Ji Young Park; Myung Hoon Lee; Ho Yong Park
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-05       Impact factor: 4.553

7.  Association between TRAIL gene polymorphisms and the susceptibility and severity of lumbar disc degeneration.

Authors:  Heng Du; Bin Bai; Yusheng Qiu; Si Yin; Weiguo Bian
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

8.  Tumor necrosis factor-related apoptosis inducing ligand gene polymorphisms are correlated with gastric cancer in central China.

Authors:  Changgao Wang; Shufang Xu; Fengming Yi; Xiaobing Wang; Yuan Lei; Sha Huang; Rui Zhou; Bing Xia
Journal:  Pharm Res       Date:  2013-11-26       Impact factor: 4.200

9.  Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls.

Authors:  Biyuan Zhu; Chaolie Xiao; Biqing Zhu; Zhiwen Zheng; Jingjing Liang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

10.  Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation.

Authors:  Mark G J de Boer; Hetty Jolink; Constantijn J M Halkes; Pim L J van der Heiden; Dennis Kremer; J H Frederik Falkenburg; Esther van de Vosse; Jaap T van Dissel
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.